Provides lidocaine spray sufficient analgesia for intravenous cannulation.

• Conditions: The enrolled subjects will get an intravenous cannulation in both elbows. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbows, the other intravenous cannulation is placed in de other arm before placebo spray is placed, the control arm. The pain score during insertion of de cannulation, the incidence of adverse events and the success rate and degree of difficulty to place an intravenous cannulation.; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2015-003915-39-NL

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-29
• Last Update Posted: 11 April 2016

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Adults (aged 18 or older)
Signing of the informed consent paper
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 17
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Allergy for xylocaine
Pregnancy or breast-feeding
Peripheral neuropathy
Analgesics in the last 24 hours
Skin conditions (eczema, psoriasis, infection, or abrasions)
Difficulties in verbal communication
No intravenous access in both elbows possible (eg status after axillary dissection)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified